These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23958588)

  • 61. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
    Gupta S; Singh S
    BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
    Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
    J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong.
    Chan HL; Tsang SW; Wong ML; Tse CH; Leung NW; Chan FK; Sung JJ
    Am J Gastroenterol; 2002 Oct; 97(10):2629-33. PubMed ID: 12385451
    [TBL] [Abstract][Full Text] [Related]  

  • 64. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genotype impact on long-term virological outcome of chronic hepatitis B virus infection.
    Malmström S; Eilard A; Larsson SB; Hannoun C; Norkrans G; Lindh M
    J Clin Virol; 2012 Aug; 54(4):321-6. PubMed ID: 22608364
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
    Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
    J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Case report. Hepatitis B virus and HIV coinfection.
    Piliero PJ; Faragon JJ
    AIDS Read; 2002 Oct; 12(10):443-4, 448-51. PubMed ID: 12408101
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
    Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C.
    Raffa G; Maimone S; Cargnel A; Santantonio T; Antonucci G; Massari M; Schiavini M; Caccamo G; Pollicino T; Raimondo G
    AIDS; 2007 Oct; 21(16):2171-5. PubMed ID: 18090043
    [TBL] [Abstract][Full Text] [Related]  

  • 70. More improvement than progression of liver fibrosis following antiretroviral therapy in a longitudinal cohort of HIV-infected patients with or without HBV and HCV co-infections.
    Ding Y; Duan S; Ye R; Yang Y; Yao S; Wang J; Cao D; Liu X; Lu L; Jia M; Wu Z; He N
    J Viral Hepat; 2017 May; 24(5):412-420. PubMed ID: 27925409
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
    Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
    J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Brief Report: HIV/HBV Coinfection is a Significant Risk Factor for Liver Fibrosis in Tanzanian HIV-Infected Adults.
    Hawkins C; Christian B; Fabian E; Macha I; Gawile C; Mpangala S; Ulenga N; Thio CL; Ammerman LR; Mugusi F; Fawzi W; Green R; Murphy R
    J Acquir Immune Defic Syndr; 2017 Nov; 76(3):298-302. PubMed ID: 29016448
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: therapeutic implications.
    Pérez-Olmeda M; Núñez M; García-Samaniego J; Ríos P; González-Lahoz J; Soriano V
    AIDS Res Hum Retroviruses; 2003 Aug; 19(8):657-9. PubMed ID: 13678467
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diagnostic accuracy of the Coopscore
    Taibi L; Boyd A; Bosselut N; Bottero J; Guéchot J; Lacombe K; Lasnier E; Baudin B; Vaubourdolle M
    Ann Clin Biochem; 2018 Mar; 55(2):236-243. PubMed ID: 28661201
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared.
    Wandeler G; Mulenga L; Vinikoor MJ; Kovari H; Battegay M; Calmy A; Cavassini M; Bernasconi E; Schmid P; Bolton-Moore C; Sinkala E; Chi BH; Egger M; Rauch A;
    Int J Infect Dis; 2016 Oct; 51():97-102. PubMed ID: 27596685
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epidemiological and virological features of HBV infection in HIV-2 infected patients living in southeastern France.
    Colson P; Henry M; Motte A; Gallais H; Moreau J; Poizot-Martin I; Tamalet C
    Eur J Epidemiol; 2006; 21(8):615-8. PubMed ID: 17031520
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing.
    Audsley J; Littlejohn M; Yuen L; Sasadeusz J; Ayres A; Desmond C; Spelman T; Lau G; Matthews GV; Avihingsanon A; Seaberg E; Philp F; Saulynas M; Ruxrungtham K; Dore GJ; Locarnini SA; Thio CL; Lewin SR; Revill PA
    Virology; 2010 Sep; 405(2):539-47. PubMed ID: 20655563
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group.
    Crespo M; Navarro J; Moreno S; Sanz J; Márquez M; Zamora J; Ocampo A; Iribaren JA; Rivero A; Llibre JM
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):493-498. PubMed ID: 27061975
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Association between hepatitis B co-infection and elevated liver stiffness among HIV-infected adults in Lusaka, Zambia.
    Vinikoor MJ; Mulenga L; Siyunda A; Musukuma K; Chilengi R; Moore CB; Chi BH; Davies MA; Egger M; Wandeler G;
    Trop Med Int Health; 2016 Nov; 21(11):1435-1441. PubMed ID: 27499385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.